Skip to main content

Table 3 Responses to treatment by HBsAg-positive and -negative DLBCL patients according to R-CHOP and CHOP regimens

From: Clinicopathological and prognostic features of hepatitis B virus-associated diffuse large B-cell lymphoma: a single-center retrospective study in China

Treatment response

HBsAg-positive patients

HBsAg-negative patients

R-CHOP (n = 60)

CHOP (n = 66)

P value

R-CHOP (n = 143)

CHOP (n = 150)

P value

CR/CRu

42

36

0.082

114

82

0.001

PR

15

25

 

28

55

 

SD

0

1

 

1

3

 

PD

3

4

 

0

10

 
  1. CHOP cyclophosphamide, doxorubicin, vincristine and prednisone, R-CHOP addition of rituximab to CHOP, CR complete response, PR partial response, SD stable disease, PD progressive disease